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Abstract
Background: Elucidating the precise properties of cancer stem cells (CSCs) is indispensable for the development of
effective therapies against tumors, because CSCs are key drivers of tumor development, metastasis and relapse. We
previously reported that the Hoechst 33342 dye-low staining side population (SP) method can enrich for CSCs in
the C6 glioma cell line, and that the positively stained main population (MP) cells are non-CSCs. Presence of cancer
stem-like SP cells is reported in various types of cancer. Although altered cellular energy metabolism is a hallmark
of cancer, very little has been studied on the applicability of fluorescent probes for the understanding of CSC
energy metabolism.
Methods: The metabolic status of C6 SP and MP cells are evaluated by CellROX, MitoTracker Green (MTG) and JC-1
for cellular oxidative stress, mitochondrial amount, and mitochondrial membrane potential, respectively.
Results: SP cells were found to exhibit significantly lower fluorescent intensities of CellROX and MTG than MP cells.
However, inhibition of ATP binding cassette (ABC) transporters by verapamil enhanced the intensities of these
probes in SP cells to the levels similar to those in MP cells, indicating that SP cells expel the probes outside of the
cells through ABC transporters. Next, SP cells were stained with JC-1 dye which exhibits membrane potential
dependent accumulation in mitochondrial matrix, followed by formation of aggregates. The mitochondrial
membrane potential indicated by the aggregates of JC-1 was 5.0-fold lower in SP cells than MP cells. Inhibition of
ABC transporters enhanced the fluorescent intensities of the JC-1 aggregates in both SP and MP cells, the former of
which was still 2.2-fold lower than the latter. This higher JC-1 signal in MP cells was further found to be due to the
Hoechst 33342 dye existing in MP cells. When SP and MP cells were recultured to deprive the intracellular Hoechst
33342 dye and then stained with JC-1 in the presence of verapamil, the intensities of JC-1 aggregates in such SP
and MP cells became comparable.
Conclusion: Inhibiting ABC transporters and depriving Hoechst 33342 dye are required for the accurate assessment
of side population-defined C6 glioma stem cell metabolism using fluorescent probes.
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Background
Metabolic alteration in cancer cells has been considered
to be linked to cancer progression and drug resistance,
and thus characterized intensively for a long time as a
potential therapeutic target [1]. In addition, the evidence
has been accumulating that tumors contain a small subset
of stem-like cells called cancer stem cells (CSCs), a key
driver of tumor development, metastasis and relapse [2].
As CSCs among bulk cancer cells are resistant to conven-
tional chemo/radio-therapies and have critical roles in re-
currence, elucidation of their unique aspects of
metabolism is therefore expected to provide us clues to
develop novel therapeutic strategies against tumors. To
date, several researchers have investigated cellular energy
metabolism of CSCs; Zhou et al. reported that the ATP
generation in CSCs is dependent on glycolysis [3]. On the
other hand, Vlashi et al. reported that the CSC ATP gener-
ation mainly relies on oxidative phosphorylation [4].
Because the characteristics of CSC metabolism are still
controversial, it is imperative to accumulate more
evidence in more accurate ways. Previously, we reported
that the Hoechst 33342 dye-effluxing SP cells, but not the
dye-retaining MP cells of the C6 glioma cell line are rich
in CSCs with such properties as high tumorigenicity [5].
SP-defined CSCs have been reported in various types of
cells [6–10]. The high dye-effluxing activity of SP cells is
known to be dependent on ATP binding cassette (ABC)
transporters, which are also highly expressed in a variety
of normal tissue stem cells [11].
Fluorescent probes have been widely used for the
evaluation of cellular metabolic status such as intracellu-
lar reactive oxygen species (ROS) levels, mitochondrial
amount and mitochondrial membrane potential [12].
CellROX Deep Red Reagent (CellROX) is used to deter-
mine cellular ROS levels, which is non-fluorescent in the
reduced state and becomes fluorescent (excitation/emis-
sion maxima of 640/665 nm) when oxidized by intracel-
lular ROS [13]. MitoTracker Green (MTG) (excitation/
emission maxima of 490/516 nm) is a carbocyanine-
based dye widely used to evaluate the amount of
mitochondria. MTG labels mitochondria reportedly via
the interaction with anionic phospholipid cardiolipine,
which is abundant in the inner mitochondrial membrane
[14]. JC-1 is a lipophilic cationic dye for the evaluation
of mitochondrial membrane potential. The maximum
excitation wavelength of JC-1 monomers is 498 nm and
that of JC-1 aggregates is 593 nm. JC-1 molecules exist
as a monomer at low concentrations. When loaded into
the mitochondrial matrix upon membrane potential-
driven uptake, JC-1 molecules are concentrated and
form aggregates, which lead to the shift of the maximum
emission wavelength from 525 to 595 nm [15].
While extensive research has been done on the high
activity of CSCs to expel xenobiotic compounds outside
of the cells through ABC transporters, the applicability
of fluorescent probes for assessing the CSC metabolism
has not been sufficiently studied. In fact, some fluores-
cent probes are already known as substrates of ABC
transporters [16–18], but a detailed examination of the
appropriateness of their use for CSC research has not
been made. In this study, with the use of C6 glioma SP
cells as an established CSC model, we examined three
fluorescent probes, CellROX, MTG and JC-1 for their
applicability to the assessment of SP-defined CSC
metabolism, and precisely compared the metabolic
differences between CSCs and non-CSCs.
Methods
Cell culture and SP analysis
C6 cells were maintained under 5 % CO2 at 37 C in
Dulbecco’s modified Eagle’s medium (DMEM, Wako)
supplemented with 10 % fetal bovine serum (FBS) and
50 U/ml penicillin and 50 μg/ml streptomycin (Gibco).
Detection and isolation of SP cells were performed as
previously described [5]. Briefly, C6 cells were harvested
by trypsinization, resuspended in 2 % FBS-DMEM at a
final density of 1 × 106 cells/ml, and incubated in dark
with 5 μg/ml Hoechst 33342 dye for 90 min at 37 C in
the presence or absence of 50 μM verapamil. One μg/ml
propidium iodide was used to discriminate dead cells. SP
and MP cells were separated by FACS Aria II (BD
Biosciences) equipped with 355 nm UV laser. The fluor-
escence of Hoechst 33342 dye was monitored through
405/20 nm band pass filter and 670 nm long pass filter.
CellROX, MTG and JC-1 staining
Three fluorescent probes were purchased from Molecular
Probes, dissolved in dimethylsulfoxide (DMSO) (100 mM,
500 μM, and 1 mg/ml stock concentrations, respectively),
and stored at −20 C in dark. Experimental conditions were
indicated as follows: cells were resuspended in 2 % FBS-
DMEM at a density of 1 × 105 cells/ml and incubated at
37 C with 5 μM CellROX for 30 min, 100 nM MTG for
30 min, or 1 μg/ml JC-1 for 40 min. The fluorescent
probes were excited with 488 nm (for MTG and JC-1) or
633 nm (for CellROX) laser, and monitored through 530/
30 nm band pass (for MTG and JC-1 monomers), 575/
25 nm band pass (for JC-1 aggregates) or 660/20 nm band
pass (for CellROX) filter. The mean fluorescent intensity
(MFI) was calculated using FlowJo software version 7.6.5
(TOMY Digital Biology).
Statistical analysis
All data are shown as the means ± standard deviation
(SD) from three independent experiments. Significance
between experimental groups was determined by
Student’s t-test. A two-tailed value of less than 0.05 was
considered significant.
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Results
CellROX, MTG and JC-1 are excluded from SP-defined
CSCs through ABC transporters
To examine whether fluorescent probes are applicable to
the assessment of CSC metabolism, we first sorted SP
and MP cells (defined as CSCs and non-CSCs, respect-
ively) from the C6 glioma cell line by FACS. The sorted
cells were subsequently stained with three fluorescent
probes, CellROX (for ROS levels), MTG (for mitochon-
drial amount) or JC-1 (for mitochondrial membrane
potential). To see the effect of ABC transporters known
to be present at higher levels in SP cells than MP cells
and expel the Hoechst 33342 dye, the staining process
was done either in the presence or absence of 50 μM
verapamil, an inhibitor of ABC transporters. The exclu-
sion of Hoechst 33342 dye from C6 cells was negligible
at this concentration of verapamil (data not shown). The
treatment of verapamil significantly enhanced the
CellROX fluorescence in SP cells, whereas the fluores-
cence of CellROX in MP cells was not affected (Fig. 1a
and b), indicating that CellROX was excluded from SP
cells through ABC transporters and that oxidative stress
as measured by ROS formation in SP and MP cells was
comparable. Similar results were obtained from experi-
ments using MTG, which indicates that the mitochon-
drial amount is comparable in SP and MP cells (Fig. 1c
and d). The mean fluorescent intensity (MFI) of JC-1




Fig. 1 The influence of ABC transporters on the fluorescence of probes in SP and MP cells. FACS plots and mean fluorescent intensity (MFI) of
sorted C6 SP (Hoechst 33342-effluxing) and MP (Hoechst 33342-retaining) cells after staining with CellROX (a, b), MTG (c, d) and JC-1 (e-g) in the
presence or absence of verapamil. Fluorescence of each probe was analyzed using the indicated filters. The mean percentages ± SD of positive
cells per total cells are shown in plots. n.s., not significant. n = 3
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respectively lower in SP cells than MP cells without
verapamil (Fig. 1e, f, and g). The MFI of JC-1 monomers
in SP cells was significantly increased by verapamil treat-
ment and C6 SP and MP cells displayed similar levels of
fluorescent intensities of JC-1 monomers in the presence
of verapamil (Fig. 1f, the third and fourth columns),
which is comparable to that in MP cells without verap-
amil (Fig. 1f, the second column). The MFI of JC-1
aggregates in SP cells was significantly increased (by
193 %) by verapamil, and the MFI of JC-1 aggregates of
MP cells was also increased to a lesser extent (by 26 %)
(Fig. 1g). The MFI of JC-1 aggregates in SP cells was
46 % of that in MP cells in the presence of verapamil,
whereas that in SP cells, in the absence of verapamil,
was only 20 % of that in MP cells (Fig. 1g). These data
indicate that the three metabolic indicators CellROX,
MTG and JC-1 are excluded from SP cells through ABC
transporters, and thus the influence of ABC transporters
must be considered for the fluorescent probe-based
assessments of the metabolic status of SP-defined CSCs.
Considering the lower level of JC-1 aggregates in SP cells
in the presence of verapamil (Fig. 1g), C6 glioma CSCs
may seem to have lower mitochondrial membrane
potential than non-CSCs.
Hoechst 33342 dye prestaining enhances the fluorescent
intensities of JC-1 aggregates
Because the amounts of Hoechst 33342 dye in sorted SP
and MP cells are different, with the latter being very
high, the influence of Hoechst 33342 dye on the fluores-
cent intensity of JC-1 aggregates was further examined.
As shown in Fig. 2a (upper panels), C6 cells stained with
Hoechst 33342 dye displayed significantly higher levels
of JC-1 aggregates. The difference was approximately 3.2
fold (Fig. 2b, left two columns). To explain this undesir-
able effect of Hoechst 33342 dye, we tested three
a
b c
Fig. 2 The influence of prestaining with Hoechst 33342 dye on the MFI of JC-1 aggregates. a FACS plots of C6 glioma cells stained with Hoechst
33342 dye and subsequently with JC-1 in the presence of verapamil. The upper and lower panels represent data from cells analyzed with or
without Hoechst 33342-exciting 355 nm UV laser, respectively. The mean percentages ± SD of positive cells per total cells are shown in the plots.
b Bar graph representing the mean fluorescent intensity of JC-1 aggregates of the JC-1-stained cells in (a). n = 3. c FSC/SSC plots of C6 glioma
cells stained with (+) or without (−) Hoechst 33342 dye
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hypotheses; 1) 355 nm UV laser for Hoechst 33342 might
unexpectedly excite JC-1 aggregates, 2) fluorescence emit-
ted from the UV-excited Hoechst 33342 might excite JC-1
aggregates, and 3) 488 nm argon laser for JC-1 excitation
might unexpectedly excite Hoechst 33342 dye. However,
even when UV laser was shut off, the fluorescent intensity
of JC-1 aggregates in cells never decreased regardless of
the staining without or with Hoechst 33342 and the MFI
in the latter was always high (Fig. 2a, left panels and b). It
is unknown why MFI of JC-1 aggregates is somewhat en-
hanced (by 11 %) following the shut off of the UV laser
(Fig. 2b, second and fourth columns), but at least it is
obvious that 355 nm UV laser does not excite JC-1 aggre-
gates and UV laser-excited Hoechst 33342 does not excite
JC-1 aggregates. When C6 cells were stained with Hoechst
33342 dye alone and excited by the argon laser, the emit-
ted fluorescence from the cells is negligible through the
filter for JC-1 aggregates (Fig. 2a, right panels). Finally, a
possible influence of Hoechst 33342 staining on cell size
and granularity, which might affect JC-1 aggregation, was
examined. As shown in Fig. 2c, staining with Hoechst
33342 dye did not affect the size and granularity of cells
(Fig. 2c). Therefore, we cannot yet figure out how Hoechst
33342 dye influences the fluorescence of JC-1 aggregates,
but at least it is obvious that Hoechst 33342 staining inter-
feres with the assessment of mitochondrial membrane
potential using JC-1.
Fluorescent intensity of JC-1 aggregates in SP and MP
cells becomes comparable by depriving Hoechst 33342
dye and inhibiting ABC transporters
To achieve the accurate assessment of the mitochondrial
membrane potential using the JC-1 dye, sorted SP and
MP cells were recultured for 6 days to deprive intracel-
lular Hoechst 33342 dye and subjected to staining with
JC-1. These cells were confirmed to possess no or negli-
gible Hoechst 33342 dye (Fig. 3a). The recultured SP
and MP cells were then stained with Hoechst 33342
again to know SP/MP profiles of these cultured cells. As
shown in Fig. 3b, 68.9 ± 1.7 % of SP-derived cells
retained the SP phenotype, and MP-derived cells display-





Fig. 3 MFI of JC-1 becomes comparable when ABC transporters are inhibited and Hoechst dye is deprived. a Removal of intracellular Hoechst
33342 dye by reculturing SP and MP cells. Twenty thousands of cells were sorted by FACS and recultured for 6 days. b FACS plots of SP- and
MP-derived cells restainined with Hoechst 33342 dye. The mean percentages ± SD of SP-derived SP cells (left panel) or MP-derived SP cells
(right panels) detected on day 6 of reculture to derive initial Hoechst 33342 were indicated in the plots. c FACS plots of SP- and MP-derived cells
stained with JC-1 in the presence or absence of verapamil. d The mean fluorescent intensity of JC-1 aggregates was calculated and shown as bar
graphs. n.s., not significant. n = 3
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shown in Fig. 3c (upper panels) and d, the recultured
MP cells deprived of initial Hoechst 33342 dye displayed
higher levels of fluorescence whose wave length corre-
sponds to JC-1 aggregates than SP cells in the absence of
verapamil, as expected. However, SP- and MP-derived
recultured cells exhibited similar levels of fluorescence
corresponding to JC-1 aggregates in the presence of
verapamil (Fig. 3c lower panels and d), suggesting that
mitochondrial membrane potential of C6 CSCs are
comparable to that of C6 non-CSCs. Taken together, our
data indicate that the activity of ABC transporters and
the presence of Hoechst 33342 dye in cells definitely
interfere with the estimation of the metabolic status
when fluorescent probes are applied to SP-defined CSCs.
Discussion
Understanding of the metabolic status of CSCs is con-
sidered to provide clues for the development of eradica-
tive therapies against tumors. In the present study, we
assessed whether three widely used fluorescent probes
CellROX, MTG and JC-1 are applicable to the study of
metabolic differences between CSCs and non-CSCs from
the C6 glioma cell line. We here demonstrate that 1) SP-
defined rat C6 glioma CSCs expel these fluorescent
probes outside of the cells through ABC transporters,
and 2) staining with the Hoechst 33342 dye used for SP/
MP separation, in other words, identification process of
C6 glioma CSCs and non-CSCs, enhances the fluores-
cent intensity of JC-1 aggregates. Thereby, we propose
that inhibition of probe-exclusion is required for the
comparison of the metabolic status in SP-defined C6
glioma CSCs and non-CSCs with the use of fluorescent
probes. In addition, deprivation of the Hoechst 33342
dye used for C6 glioma CSC/non-CSC identification is
required for the accurate assessment of the mitochon-
drial membrane potential using JC-1.
CSCs can be isolated based on their characteristics such
as the surface expression of stem cell markers like CD133
or CD44 and low 26S proteasome activity [19]. In addition,
the SP method based on the activity of ABC transporters
which is strongly associated with anti-cancer drug-resistant
properties of CSCs is widely utilized to enrich CSCs in
many types of tumors [6–10, 20]. Our results therefore
generally provide an important caution that we may easily
misestimate the metabolic status of CSCs and non-CSCs
when fluorescent probes are used. In fact, some investiga-
tors actually compare the metabolic status of CSCs and
non-CSCs using fluorescent probes without considering
the possibility that CSCs expel such probes [21–24].
MTG and JC-1 have already been demonstrated as
substrates of ABCB1, ABCC1 and ABCG2 [16–18]. Our
previous cDNA microarray data for the expression of
some ABC transporter genes (available in NCBI GEO
repository #GSE72431) reveal that only ABCB1 gene is
specifically upregulated in C6 glioma SP cells compared
with MP cells approximately by 10.6-fold (SP:MP =
0.64:0.060), suggesting that the ability of SP cells to expel
xenobiotics is mainly dependent on ABCB1 in C6 cells
[25, 26]. In addition, it has been reported that ABCB1 is
overexpressed in human glioma tissues and its expres-
sion level is strongly correlated with that of another
glioma CSC marker CD133, suggesting the importance
of ABCB1 in glioma CSCs [27]. We also show here that
CellROX is a newly identified substrate of verapamil-
targeted ABC transporters, as well as that MTG and
JC-1 are substrates of ABC transporters in glioma.
In Figs. 1g and 3d, we observed a slight enhancement
of JC-1 aggregates, but not JC-1 monomers, in MP cells
treated with verapamil despite the fact that the MFI of
CellROX and MTG in these cells were not affected by
this treatment. Concerning this phenomenon, verapamil
might inhibit the ABC transporters barely existing in the
mitochondrial inner membrane which may possibly
regulate the concentration of JC-1 in mitochondrial
inner membrane, eventually affecting the formation of
red aggregates. However, the presence of ABC trans-
porters in mitochondrial inner membrane and effects of
verapamil to them in C6 glioma cells should be further
investigated. In any case, the increase in MFI of the JC-1
aggregates in MP cells treated with verapamil was much
lower compared with that observed in SP cells.
As for the mechanisms underlying the enhancement of
the fluorescent signal corresponding to JC-1 aggregates by
Hoechst prestaining, it is possible that colocalization of
JC-1 molecules with the dye in the mitochondrial matrix
or mitochondrial DNA damage induced by Hoechst stain-
ing [28] might change the fluorescent properties of JC-1
aggregates or the aggregating efficiency of JC-1 monomers
in mitochondria. One paper reported that Hoechst 33342
dye opposingly decreases mitochondrial membrane poten-
tial measured by JC-1 in the myelogenous leukemia cell
line HL-60 [29]. The influence of Hoechst 33342 dye
might differ depending on the tissue types of tumor origin
or subpopulations within tumor cells. In any case, there-
fore, attention should be paid to the effect of Hoechst
33342 on the fluorescence of JC-1 aggregates.
Altogether, establishing the accurate methods to
precisely characterize CSCs will help us identifying ideal
targets and develop eradicative therapies against cancer,
though it is indispensable to further consider the influ-
ence of in vivo microenvironment such as hypoxia, low
nutrients, and inflammation for thorough elucidation of
the complex properties of CSC metabolism.
Conclusion
We provide important cautions for the fluorescent
probe-based assessments of cellular metabolism in C6
glioma CSCs isolated by the SP method, i.e. requirement
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of ABC transporter inhibition and Hoechst 33342 dye
deprivation, by demonstrating the ability of glioma SP
cells to expel fluorescent probes and the unexpected
effect of Hoechst 33342 on the fluorescence correspond-
ing to JC-1 aggregates. This study also suggests that
ROS levels, mitochondrial amount and mitochondrial
membrane potential of C6 glioma CSCs were compar-
able to those of non-CSCs.
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